Allurion Technologies (ALURD) Cash from Financing Activities (2022 - 2026)
Allurion Technologies (ALURD) Cash from Financing Activities (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 186.78 Bn | 179.48 Bn | 6.27 Bn | 17.31 Bn |
| 2 | Stryker | 131.95 Bn | 129.07 Bn | 3.81 Bn | -1.51 Bn |
| 3 | Medtronic | 111.27 Bn | 102.05 Bn | 6.41 Bn | -888.00 Mn |
| 4 | Boston Scientific | 68.58 Bn | 67.13 Bn | 3.61 Bn | -260.00 Mn |
| 5 | Edwards Lifesciences | 48.31 Bn | 44.63 Bn | 1.29 Bn | -451.20 Mn |
| 6 | GE HealthCare Technologies | 29.23 Bn | 26.94 Bn | 1.98 Bn | 21.00 Mn |
| 7 | Dexcom | 28.90 Bn | 27.78 Bn | 750.30 Mn | -25.00 Mn |
| 8 | Smith & Nephew | 28.19 Bn | 27.62 Bn | - | - |
| 9 | Koninklijke Philips | 24.33 Bn | 21.29 Bn | 2.01 Bn | -26.17 Mn |
| 10 | Allurion Technologies | 60.75 Mn | 55.69 Mn | 1.23 Mn | 2.87 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.87 Mn |
| Mar 31, 2026 | 2.87 Mn |
| Dec 31, 2025 | 4.60 Mn |
| Dec 31, 2025 | 4.60 Mn |
| Sep 30, 2025 | -55,000.00 |
| Sep 30, 2025 | -55,000.00 |
| Jun 30, 2025 | -71,000.00 |
| Jun 30, 2025 | -71,000.00 |
| Mar 31, 2025 | 14.50 Mn |
| Mar 31, 2025 | 14.50 Mn |
| Dec 31, 2024 | -53,000.00 |
| Dec 31, 2024 | -53,000.00 |
| Sep 30, 2024 | 20.93 Mn |
| Sep 30, 2024 | 20.93 Mn |
| Jun 30, 2024 | -1.06 Mn |
| Jun 30, 2024 | -1.06 Mn |
| Mar 31, 2024 | 387,000.00 |
| Mar 31, 2024 | 387,000.00 |
| Dec 31, 2023 | -20.41 Mn |
| Dec 31, 2023 | -20.41 Mn |